Waldenstrom Macroglobulinemia
Symptoms, Doctors, Treatments, Advances & More

Learn About Waldenstrom Macroglobulinemia

What is the definition of Waldenstrom Macroglobulinemia?

Waldenström macroglobulinemia (WM) is a cancer of the B lymphocytes (a type of white blood cell). WM is associated with the overproduction of proteins called IgM antibodies.

What are the alternative names for Waldenstrom Macroglobulinemia?

Waldenström macroglobulinemia; Macroglobulinemia - primary; Lymphoplasmacytic lymphoma; Monoclonal macroglobulinemia; Waldenström macroglobulinemia

What are the causes of Waldenstrom Macroglobulinemia?

WM is a result of a condition called lymphoplasmacytic lymphoma. This is a cancer of the white blood cells, in which the B immune cells start dividing rapidly. The exact cause of too much production of the IgM antibody is unknown. Hepatitis C may increase the risk of WM. Gene mutations are often found in the malignant B cells.

Production of excess IgM antibodies can cause several types of problems:

  • Hyperviscosity, which causes the blood to become too thick. This can make it harder for blood to flow through small blood vessels.
  • Neuropathy, or nerve damage, when the IgM antibody damages nerve tissue.
  • Anemia, when abnormal IgM antibodies bind to red blood cells and cause them to be destroyed, or when Waldenström macroglobulinemia cells accumulate in the bone marrow, reducing its ability to produce normal red blood cells.
  • Anemia, when the IgM antibody binds to red blood cells and damages them or abnormal cells crowd out normal blood-forming cells.
  • Kidney disease, when the IgM antibody deposits in kidney tissue.
  • Cryoglobulinemia and vasculitis (inflammation of the blood vessels) when the IgM antibody forms immune complexes with cold exposure.

WM is very rare. Most people with this condition are over 65 years of age.

What are the symptoms of Waldenstrom Macroglobulinemia?

Symptoms of WM may include any of the following:

  • Bleeding of the gums and nosebleeds
  • Blurred or decreased vision
  • Bluish skin in the fingers after cold exposure
  • Dizziness or confusion
  • Easy bruising of the skin
  • Fatigue
  • Diarrhea
  • Numbness, tingling, or burning pain in the hands, feet, fingers, toes, ears, or nose
  • Rash
  • Swollen glands
  • Unintentional weight loss
  • Vision loss in one eye
Not sure about your diagnosis?
Check Your Symptoms
What are the current treatments for Waldenstrom Macroglobulinemia?

Some people with WM who have increased IgM antibodies do not have symptoms. This condition is known as smoldering WM. No treatment is needed other than careful follow-up.

In people with symptoms, treatment aims at decreasing the symptoms and the risk of developing organ damage. There is no current standard treatment but there are now numerous effective treatments available. Your health care provider may suggest that you participate in a clinical trial.

Plasmapheresis removes IgM antibodies from the blood. It also controls the symptoms caused by blood thickening. This may need to be done urgently if the IgM level is very high and causing symptoms.

Medicines may include corticosteroids, a combination of chemotherapy medicines and the monoclonal antibody to B cells, rituximab. Newer drugs such as BTK inhibitors are very effective.

Autologous stem cell transplant may be recommended for some people with otherwise good health although this is now done infrequently.

People who have a low number of red or white blood cells or platelets may need transfusions or antibiotics.

Who are the top Waldenstrom Macroglobulinemia Local Doctors?
Elite in Waldenstrom Macroglobulinemia
Hematology | Oncology
Elite in Waldenstrom Macroglobulinemia
Hematology | Oncology
Referral may be required

MN - Cancer Transplant

200 1st St SW, 
Rochester, MN 
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Prashant Kapoor is a Hematologist and an Oncologist practicing medicine in Rochester, Minnesota. Dr. Kapoor is rated as an Elite provider by MediFind in the treatment of Waldenstrom Macroglobulinemia. He is also highly rated in 18 other conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Waldenstrom Macroglobulinemia, Primary Amyloidosis, Monoclonal Gammopathy of Undetermined Significance (MGUS), and Bone Marrow Transplant. Dr. Kapoor is currently accepting new patients.

Elite in Waldenstrom Macroglobulinemia
Elite in Waldenstrom Macroglobulinemia
Referral may be required

MN - Cancer Hematology

200 1st St SW, 
Rochester, MN 
Languages Spoken:
English
Accepting New Patients

Jithma Abeykoon is a Hematologist practicing medicine in Rochester, Minnesota. Dr. Abeykoon is rated as an Elite provider by MediFind in the treatment of Waldenstrom Macroglobulinemia. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Reticulohistiocytoma, Histiocytosis, Waldenstrom Macroglobulinemia, Tissue Biopsy, and Bone Marrow Transplant. Dr. Abeykoon is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Waldenstrom Macroglobulinemia
Elite in Waldenstrom Macroglobulinemia
Referral may be required
Athens, ESYE31, GR 

Maria Gavriatopoulou practices practicing medicine in Athens, Greece. Ms. Gavriatopoulou is rated as an Elite expert by MediFind in the treatment of Waldenstrom Macroglobulinemia. She is also highly rated in 15 other conditions, according to our data. Her clinical expertise encompasses Multiple Myeloma, Waldenstrom Macroglobulinemia, Primary Amyloidosis, Bone Marrow Aspiration, and Bone Marrow Transplant.

What is the outlook (prognosis) for Waldenstrom Macroglobulinemia?

The median survival is about 8 years but this varies widely. New highly effective treatment options have improved the outcome for many patients.

In some people, the disorder may produce few symptoms and progress slowly.

What are the possible complications of Waldenstrom Macroglobulinemia?

Complications of WM may include:

  • Changes in mental function, possibly leading to coma
  • Heart failure
  • Gastrointestinal bleeding or malabsorption
  • Vision problems
  • Hives
When should I contact a medical professional for Waldenstrom Macroglobulinemia?

Contact your provider if symptoms of WM develop.

What are the latest Waldenstrom Macroglobulinemia Clinical Trials?
BAF_FRontier-1, A First-in-Human, Phase 1 Trial to Assess Safety, Tolerability, and Preliminary Efficacy of LY4152199, a B-cell Activation Factor Receptor (BAFF-R) T-Cell Engager Bispecific Antibody in Adult Participants With Previously Treated B-cell Malignancies

Summary: The purpose of this study is to find the best dose of the drug and measure the safety and efficacy of LY4152199 in participants with previously treated B-cell malignancies. Participants will have the option to continue taking LY4152199 until the study ends.

Match to trials
Find the right clinical trials for you in under a minute
Get started
Natural History Study of Monoclonal B Cell Lymphocytosis (MBL), Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL), Lymphoplasmacytic Lymphoma (LPL)/Waldenstrom Macroglobulinemia (WM), and Splenic Marginal Zone Lymphoma (SMZL)

Eligibility: * Diagnosis of CLL/SLL and on treatment/previously treated/nearing treatment * Diagnosis of LPL/WM * As of February 5, 2025, patients with MBL and SMZL will no longer be enrolled. * Age greater than or equal to 18 years. * ECOG performance status of 0-2. Design Patients are typically followed every 6 to 24 months in the clinic and have blood drawn. Patients may be asked to undergo additional testi...

Who are the sources who wrote this article ?

Published Date: May 01, 2026
Published By: Warren Brenner, MD, Oncologist, Lynn Cancer Institute, Boca Raton, FL. Review provided by VeriMed Healthcare Network. Also reviewed by David C. Dugdale, MD, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.

What are the references for this article ?

Castillo JJ, Treon SP. Waldenström macroglobulinemia/lymphoplasmacytic lymphoma. In: Hoffman R, Benz EJ, Silberstein LE, et al, eds. Hematology: Basic Principles and Practice. 8th ed. Philadelphia, PA: Elsevier; 2023:chap 92.

National Cancer Institute website. Indolent B-Cell non-Hodgkin lymphoma treatment (PDQ)–Health professional version. www.cancer.gov/types/lymphoma/hp/indolent-b-cell-lymphoma-treatment-pdq. Updated May 14, 2025. Accessed August 15, 2026.

Rajkumar SV. Plasma cell disorders. In: Goldman L, Cooney KA, eds. Goldman-Cecil Medicine. 27th ed. Philadelphia, PA: Elsevier; 2024:chap 173.